Eric G. Davis, MD | Authors

An Argument for Aggressive Resection in Melanoma

October 15, 2013

Any minimization of therapy in the name of reducing morbidity requires careful consideration. Reducing morbidity in melanoma is certainly a laudable goal, but locoregional disease control and cure must remain our primary objectives.

Extending the Role of Hepatic Metastasectomy in Stage IV Melanoma and Breast Cancer: Patient Selection is Critical

November 15, 2011

Resection of liver metastases represents a major advance of the last few decades in the treatment of colorectal cancer.